We are live on ! Find out more
CH

CVS Health Portfolio holdings

AUM $225M
1-Year Est. Return 8.77%
This Fund
S&P 500
This Quarter Est. Return
+6.21%
1 Year Est. Return
+8.77%
3 Year Est. Return
+48.72%
5 Year Est. Return
10 Year Est. Return
AUM
$230M
AUM Growth
+$13.4M
Cap. Flow
-$72.8K
Cap. Flow %
-0.03%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
LMDXW
LumiraDx Limited Warrant
LMDXW
+$72.8K

Sector Composition

Rank Sector Weight
1 Financials 0.14%
2 Healthcare 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$812B
$165M 71.75%
287,891
VYM icon
2
Vanguard High Dividend Yield ETF
VYM
$83.4B
$32.3M 14.04%
252,032
HDV
3
iShares Core High Dividend ETF
HDV
$15.3B
$32.1M 13.95%
1,365,550
PRU icon
4
Prudential Financial
PRU
$42.2B
$325K 0.14%
2,683
HCAT icon
5
Health Catalyst
HCAT
$127M
$263K 0.11%
32,273
LMDXW
6
DELISTED
LumiraDx Limited Warrant
LMDXW
-5,352,106
Closed -$72.8K

Similar funds

CVS Health's Q3 2024 Portfolio in Review

As of Q3 2024, CVS Health held 6 positions worth $230M, up 6.2% from $217M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

CVS Health's Q3 2024 filing shows 1 closed position. The largest sale was LumiraDx Limited Warrant, an estimated $72.8K.

By sector, the portfolio is most concentrated in Financials at 0.14% of assets, down from 0.14% a quarter earlier, followed by Healthcare.

  • CVS Health fully exited LumiraDx Limited Warrant in Q3 2024, selling an estimated $72.8K.
  • CVS Health's ten largest holdings make up 100% of its $230M portfolio in Q3 2024.
  • CVS Health opened 0 new positions and closed 1 in Q3 2024.
  • CVS Health's portfolio value rose 6.2% quarter-over-quarter to $230M.

Based on CVS Health's 13F filing for Q3 2024, filed 8 Nov 2024.